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Synchronous primary malignancies of the female
genital tract consitute 1.7% of all genital malignancies
(1). The most common synchronous primary
malignancies of the female genital tract are those of the
ovary and endometrium (51.7%) (1). It is not usually
possible to determine whether these tumours represent
metastases from the endometrium or ovary or separate
primary neoplasms. Rarely are the two neoplasms
histologically disparate. The choice of treatment and the
prognosis depend on whether these tumours represent
primary tumours or metastases (2). The DNA ploidy level
of the primary tumour is often maintained in the
metastases and the probability that independent tumours
will have the same DNA content is low.
This report describes a patient with three
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simultaneous malignancies. These tumours were
examined by flow cytometric DNA ploidy analysis to
detect the presence of similar DNA stemlines which would
make a metastatic process more likely (3).
A seventy-one-year-old postmenopausal woman was
admitted to Akdeniz University, Faculty of Medicine,
Department of Gynecology and Obstetrics with pelvic
pain.
Upon gynecological examination, she was found to
have left ovarian semisolid mass of approximately 10 cm.
Ultrasonographic examination revealed a calculus in the
gall bladder. No other abnormalities were detected. Two
days after admission, a total abdominal hysterectomy,
bilateral salphingoopherectomy, partial omentectomy and
cholecytectomy were performed. Examination of the
Figure 1.

Endometrial carcinoma in the
endometrial polyp. (H&E X20)
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surgical specimen from the total abdominal hysterectomy
revealed a broad-based polypoid mass measuring 2x1x1
cm in the uterine cavity. In the wall of the uterus,
extensive adenomyosis was observed through the
microscope. The endometrial glands in the endometrial
polyp were composed of back-to-back glands, lined with
large cells with abundant eosinophilic cytoplasm and
nuclear atypia (Figure 1). Most of the tumour consisted
of dense tubular formations and dilated glands. The
stroma of the endometrial adenocarcinoma generally had
a desmoplastic quality. These findings were determined as
well-differentiated
endometrial
adenocarcinoma
(endometrioid type). The ovary measured 4x3x1.5 cm.
The tumour in the ovary was 4x3x0.8 cm. It had solid
and cystic areas. The contents of the cysts were
serohemorrhagic. Microscopic examination showed that
the tumour had a glandular growth pattern with irregular
budding and luminar reduplication. The glandular buds
had smooth, rounded contours which were lined with a
tall columnar pseudostrafied or multilayered epithelium
(Figure 2). There was cellular debris in these gland-like
spaces. The solid areas showed complex glandular and
microglandular patterns. Epithelial multilayering,
Table 1.

The results of flow cytometric ploidy analysis.

aneuploid %

diploid %

DNA index

Endometrial carcinoma

56,8

43,2

1,3

Endometrioid carcinoma

15,4

84,6

1,6

Gall bladder carcinoma

14,8

85,2

1,5

pleomorphism, mitotic activity and nuclear atypia were
prominent. Necrosis and hemorrhage were obvious. This
tumour was located in deep ovarian stroma. The tumour
did not extend beyond the ovarian cortex. The ovarian
tumour was diagnosed as a poorly differentiated primary
ovarian carcinoma. The appearance of the ovarian
neoplasm was similar to that of the endometrial
malignancy. This lesion probably represented an ovarian
primary endometrioid carcinoma, and for this reason
from the uterus to the ovary could not be expected. The
endometrial carcinoma in the endometrial polyp was
restricted. No microscopic evidence of a tumour was
observed in the other ovary, the tubes or omentum. In
the gall bladder, a polypoid mass measuring 0.3 x 0.5 x
0.5 cm was observed on the surface of the mucosa. There
is a cluster of atypical glands. Well-formed glands with
wide lumina were lined with atypical cuboidal cells (Figure
3). Superficial muscular invasion was also obsserved.
These findings supported the diagnosis of welldifferentiated gall bladder adenocarcinoma.
Flow cytometry was performed on paraffinembedded material. The DNA content was measured with
an ICS-22 flow cytometer. The results of the ploidy
analysis of the three tumours are summarized in Table 1
and illustrated in Figures 4 and 5.
After the operation, the patient’s family initially
refused to allow chemotheraphy but, three months later,
with their consent, a PAC chemotheraphy (cis-platin,
adrioblastin, cyclophosphamide) program was begun.
Three days after the first PAC chemotheraphy session,
severe neutropenia was detected. The neutropenic

Figure 2.
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Figure 3.
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condition was corrected with GM-CSF and, three weeks
after she was discharged, she died of cardiopulmonary
arrest.
Simultaneous occurrence of endometrial carcinoma
and endometrioid carcinoma of the ovary with coexisting
gall bladder carcinoma is rare.
Endometrioid carcinoma comprises 10%-25% of all
primary ovarian carcinoma (4). The association of the
endometrioid carcinoma of the ovary and endometrial
adenocarcinoma is well recognized (5). The incidence of
endometrial carcinoma in patients with endometrioid
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ovarian carcinoma is 15.8% (6). Simultaneous
appearance of these lesions raises the question of
whether they can be treated only with total abdominal
hysterectomy and bilateral salphingooophorectomy (TAHBSO) (2). If the endometrial component of the
simultaneous tumours is small and superficial, it is likely
to be presented as synchronous neoplasms. However,
deep invasive endometrial tumours raise the likelihood of
ovarian metastasis from the endometrial carcinoma.
Other criteria proposed include the size of the ovarian
tumour, number of neoplastic foci, bilaterality, vascular
invasion and tubal involvement (7).

189

A Patient With Three Simultaneously Occurring Malignancies

In this case, the patient had two malignant tumours of
the genital tract and gall bladder carcinoma. The DNA
contents were measured by DNA flow cytometry establish
whether the neoplasms represented a synchronous
occurrence or metastatic spread. The flow cytometric
DNA contents of the patient’s tumours revealed that the
samples contained both diploid and aneuploid
populations.
According to previous reports, similar DNA values
suggest separate origins for two tumours (8). The
presence of different DNA contents is evidence for there
being separate synchronous neoplasms for the tumors.
Symond et al. observed the following theoretically
possible permutation of ploidy level in tumours at two
separate sites: 1) identity as evidenced by similar DNA
indices, 2) nonidentity as evidenced by differing DNA
indices, 3) an indeterminate status when both indices are
in diploidy modes (7).
The endometrial tumour displayed one ancuploid
population with a DNA index (DI) of 1.3, whereas the
endometrioid tumour had one aneuploid population (DI:

1.6) which differed from that of the endometrial lesion.
The gall bladder carcinoma had a different DI from both
of them.
In this case, a metastatic process can not be excluded
completely because of the histologic similarity of the
malignancies. Because of the total absence of tubal
involvement, myometrial spread of the endometrial
carcinoma and vascular or lymphatic invasion, a
metastatic origin of one of the two tumours seems
unlikely. The difference in the DI of the two lesions is an
additional argument for independent origins.
The authors believe that DNA flow cytometry can be
helpful in tracing the origin of distant metastases and
discriminating between intragenital metastatic disease
and multiple primary tumours. As the incidence of
endometrial carcinoma is 15.8%, the application of DNA
ploidy analysis may be of clinical value. We report this
case because of the rare occurrence of simultaneous gall
bladder carcinoma with two coexisting malignant
tumours of the genital tract.
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